References
- MoritaKKogaTMoroiYUrabeKFurueMRapid effects of olopatadine hydrochloride on the histamine-induced skin responsesJ Dermatol20022970971212484432
- O’DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol19971361972019068731
- KozelMMSabroeRAChronic urticaria: aetiology, management and current and future treatment optionsDrugs2004642515253615516152
- GreavesMWChronic idiopathic urticariaCurr Opin Allergy Clin Immunol2003336336814501436
- PowellRJDu ToitGLSiddiqueNBSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy20073763165017456211
- KozelMMMekkesJRBossuytPMBosJDNatural course of physical and chronic urticaria and angioedema in 220 patientsJ Am Acad Dermatol20014538739111511835
- Van der VafkPGMoretGKiemeneyLAThe natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centreBr J Dermatol200214611011311841375
- MonroeEReview of H1 antihistamines in the treatment of chronic idiopathic urticariaCutis20057611812616209158
- BelsitoDVSecond-generation antihistamines for the treatment of chronic idiopathic urticariaJ Drugs Dermatol2010950351220480793
- OhmoriKHayashiKKaiseTPharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride: a new antiallergic drugJpn J Pharmacol20028837939712046981
- OhmoriKHasegawaKTamuraTProperties of olopatadine hydrochloride, a new antiallergic/antihistaminic drugArzneimittelforschung20045480982915646365
- TakahashiHZhangYMoritaEEvaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresisArch Dermatol Res200830029129518305947
- TakahashiHIshida-YamamotoAIizukaHEffects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performanceClin Exp Dermatol20042952653215347340
- OkuboYShigokaYYamazakiMTsuboiRDouble dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of lifeJ Dermatolog Treat Epub August 24, 2011.
- GrattanCEO’DonnellBFFrancisDMRandomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticariaBr J Dermatol200014336537210951147
- StaubachPEckhardt-HennADecheneMQuality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidityBr J Dermatol200615429429816433799
- PassalacquaGBousquetJBachertCThe clinical safety of H1-receptor antagonists. An EAACI position paperAllergy1996516666758904993
- WelchMJMeltzerEOSimonsFEH1-antihistamines and the central nervous systemClin Allergy Immunol20021733738812113223
- KameiHIsajiANodaYEffects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteersArch Dermatol Res201230426327222130869
- KameiHNodaYIshikawaKComparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteersHum Psychopharmacol20031861161814696020
- EnomotoTLuHQYinMEvaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unitJ Investig Allergol Clin Immunol200919299305
- EisenSAMillerDKWoodwardRSSpitznagelEPrzybeckTRThe effect of prescribed daily dose frequency on patient medication complianceArch Intern Med1990150188118842102668
- GuestJFDavieAMRuizFJGreenerMJSwitching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costsPrim Care Respir J200514889816701704